سوق القنب الطبي في الشرق الأوسط وأفريقيا – اتجاهات الصناعة والتوقعات حتى عام 2030

Customize Your Report تخصيص تقريرك Buy Now اشتري الآن Free Sample Report تقرير عينة مجاني
Home Pharmaceutical Middle East And Africa Medical Cannabis Market
Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

سوق القنب الطبي في الشرق الأوسط وأفريقيا – اتجاهات الصناعة والتوقعات حتى عام 2030

  • Pharmaceutical
  • Published Report
  • May 2023
  • MEA
  • 350 الصفحات
  • عدد الجداول: 499
  • عدد الأرقام: 51
Buy Now اشتري الآن

Middle East And Africa Medical Cannabis Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Diagram فترة التنبؤ
 2024 –2030
Diagram حجم السوق (السنة الأساسية)
 مليون دولار أمريكي
طلب
Diagram حجم السوق (سنة التنبؤ)
 USD MILLION
Request For Unlock
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
طلب فتح القفل

>سوق القنب الطبي في الشرق الأوسط وأفريقيا، حسب المنتج (الزيت، كبسولات القنب الطبي، الرقعة، الزهرة الكاملة، الزهرة المطحونة، قلم التبخير، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها)، المصدر (طبيعي وصناعي)، الأنواع (القنب إنديكا، ساتيفا، والهجين)، التطبيق ( مرض الزهايمر ، فقدان الشهية، السرطان، أمراض الأمعاء الالتهابية، اضطرابات الأكل، الصرع، التوحد، حالات الصحة العقلية، التصلب المتعدد، إدارة الألم، الغثيان، تشنجات العضلات، متلازمة الهزال (الضمور العضلي)، تحسين الحالة المزاجية، الاكتئاب واضطرابات النوم، القلق، وغيرها)، المشتقات (كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها)، نوع العلاج (طارد للبلغم، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها)، طريق الإدارة (المحاليل الفموية والكبسولات، التدخين، أجهزة التبخير، الموضعية، وغيرها)، المستخدم النهائي (صناعة الأدوية، مراكز البحث والتطوير، بيئة الرعاية المنزلية، المستشفى، مراكز إعادة التأهيل وغيرها)، قناة التوزيع (B2B وB2C) - اتجاهات الصناعة وتوقعاتها حتى عام 2030.

سوق القنب الطبي في الشرق الأوسط وأفريقيا

تحليل ورؤى حول سوق القنب الطبي في الشرق الأوسط وأفريقيا

ومن المتوقع أن يؤدي ارتفاع عدد المرضى المصابين بالأمراض المزمنة في الشرق الأوسط وأفريقيا والميل المتزايد نحو نمط حياة صحي إلى دفع نمو السوق. بالإضافة إلى ذلك، من المتوقع أن يؤدي ارتفاع عدد الموافقات على المنتجات وزيادة أنشطة البحث والتطوير لأجهزة القنب الطبي إلى دفع نمو السوق. ومع ذلك، من المتوقع أن تؤدي التكلفة العالية لأجهزة وإجراءات القنب الطبي والأدوية الطبية والمخاوف المتعلقة بالسلامة والآثار السلبية المرتبطة بإجراءات الليزر والافتقار إلى الوعي بالعلاج بأجهزة الليزر إلى كبح نمو السوق. ومن المتوقع أن تعمل التطورات التكنولوجية الإضافية في القنب الطبي والمبادرات الاستراتيجية من قبل اللاعبين الناشئين كفرص لنمو السوق. ومع ذلك، من المتوقع أن تشكل اللوائح الصارمة ونقص المهنيين المهرة تحديًا لنمو السوق.

سوق القنب الطبي في الشرق الأوسط وأفريقيا

سوق القنب الطبي في الشرق الأوسط وأفريقيا

لا يتم اختبار استخدام القنب كدواء بشكل صارم بسبب القيود الحكومية مما يؤدي إلى أبحاث سريرية محدودة لتحديد فعالية القنب في التطبيقات الطبية والسريرية. ومع ذلك، تشير الدراسات الأولية إلى أن القنب يقلل من القيء والغثيان لدى مرضى العلاج الكيميائي ويساعد في زيادة الشهية.

تحلل شركة Data Bridge Market Research أن سوق القنب الطبي في الشرق الأوسط وأفريقيا من المتوقع أن ينمو بمعدل نمو سنوي مركب نسبته 21.7٪ خلال الفترة المتوقعة من 2023 إلى 2030.

تقرير القياس

تفاصيل

فترة التنبؤ

2023 إلى 2030

سنة الأساس

2022

سنة تاريخية

2021 (قابلة للتخصيص حتى 2015 – 2020)

وحدات كمية

الإيرادات بالملايين من الدولارات الأمريكية

القطاعات المغطاة

المنتج (الزيت، كبسولات القنب الطبي، الرقعة، الزهرة الكاملة، الزهرة المطحونة، قلم التبخير، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها)، المصدر (طبيعي وصناعي)، الأنواع (القنب إنديكا، ساتيفا، والهجين)، الاستخدام (مرض الزهايمر، فقدان الشهية، السرطان، أمراض الأمعاء الالتهابية، اضطرابات الأكل، الصرع، التوحد، حالات الصحة العقلية، التصلب المتعدد، إدارة الألم، الغثيان، تشنجات العضلات، متلازمة الهزال (الضمور العضلي)، تحسين الحالة المزاجية، الاكتئاب واضطرابات النوم، القلق، وغيرها)، المشتقات (كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها)، نوع العلاج (طارد للبلغم، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها)، طريق الإدارة (المحاليل الفموية والكبسولات، التدخين، أجهزة التبخير، الموضعية، وغيرها)، المستخدم النهائي (صناعة الأدوية، مراكز البحث والتطوير، بيئة الرعاية المنزلية، المستشفى، مراكز إعادة التأهيل وغيرها)، قناة التوزيع (B2B وB2C)

الدول المغطاة

إسرائيل وجنوب أفريقيا ولبنان والإمارات العربية المتحدة والكويت وبقية دول الشرق الأوسط وأفريقيا

الجهات الفاعلة في السوق المشمولة

MediPharm Labs Inc.، Tilray، Aurora Cannabis، JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)، HEXO Corp. (Zenabis Middle East and Africa Ltd)، Cresco Labs، Peace Naturals Project Inc.، CANOPY GROWTH CORPORATION، Medical Marijuana, Inc.، Seed Cellar، EcoGen Biosciences، CANNABIS SEEDS USA، Seeds For Me، HUMBOLDT SEED COMPANY، Extractas، World Class Cannabis Seeds (Crop King Seeds)، BARNEY'S FARM، FOLIUM BIOSCIENCES، PharmaHemp، Elixinol Middle East and Africa Limited، ENDOCA، Harmony، MARY'S nutritions, LLC، Pure Ratios، Greenwich Biosciences, Inc.، Upstate Elevator Supply Co.، Apothecanna، BOL Pharma، وIDT Australia وغيرها

تعريف السوق

القنب هو عقار نفسي مشتق من نبات القنب من عائلة القنبيات. منذ عدة سنوات، تم استخدامه طبيًا وله مجموعة واسعة من التطبيقات في علاج أمراض مختلفة بما في ذلك الألم المزمن والسرطان والاكتئاب والسكري والتهاب المفاصل والزرق والصرع والصداع النصفي والإيدز ومرض الزهايمر وغيرها.

ومن المتوقع أن يؤدي الاستخدام المتزايد للقنب لأغراض طبية، والتشريع المنظم للقنب واستخدامه في مختلف الصناعات، والمنهجيات المتقدمة الموجودة في هذا المجال إلى دفع نمو السوق.

ديناميكيات سوق القنب الطبي في الشرق الأوسط وأفريقيا

يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. ويتم مناقشة كل هذا بالتفصيل على النحو التالي:

السائقين

  • زيادة استخدام القنب في الأدوية

يتم استخراج القنب الطبي من نباتات القنب ويمكن استخدامه لعلاج أعراض بعض الحالات الطبية والآثار الجانبية لبعض العلاجات. الشكل الأكثر شيوعًا للاستخدام الطبي للقنب هو إدارة الألم. كان هناك قبول واستخدام تدريجي للقنب الطبي مع العدد المتزايد من البلدان التي شرعت استخدام القنب لمختلف المؤشرات. تمت الموافقة على استخدام القنب الطبي من قبل إدارة الغذاء والدواء لثلاثة مؤشرات وهي أشكال نادرة وشديدة من الصرع ومتلازمة درافيت ومتلازمة لينوكس غاستو وأيضًا لعلاج التشنج في مرض التصلب المتعدد (MS).

تستخدم الماريجوانا الطبية نبات الماريجوانا أو المواد الكيميائية الموجودة فيه لعلاج الأمراض أو الحالات، وبصرف النظر عن الأدوية المعتمدة، هناك اهتمام متزايد باثنين من القنب وهما دلتا-9-تتراهيدروكانابينول وكانابيديول. وقد ثبت أن رباعي هيدروكانابينول يحسن الشهية ويقلل من التعب ويدير مشاكل وظائف العضلات بينما كان الكانابيديول فعالاً في إدارة النوبات الصرعية وعلاج الأمراض النفسية وتقليل الالتهابات.

  • تشريع القنب

يستمر استخدام وقبول القنب الطبي في التطور، حيث يسمح عدد متزايد من الولايات باستخدام مؤشرات طبية محددة. وقد شرعت العديد من البلدان الماريجوانا للأغراض الطبية أو الترفيهية بينما فرضت بعض البلدان الأخرى استخدامًا مقيدًا. في السنوات الأخيرة، شرعت عدد متزايد من الولايات في الولايات المتحدة المخدرات للأغراض الطبية أو الترفيهية. ومع انتشار تقنين القنب على نطاق واسع، أصبحت العديد من الشركات أيضًا نشطة وتتخذ مبادرات لتقنين القنب بالكامل.

يمكن النظر إلى تقنين الماريجوانا في مختلف أنحاء العالم على أنه جهد لزيادة الإيرادات الإضافية، وبهذه الطريقة سيكون هناك زيادة في الإيرادات دون رفع الضرائب. سيسمح تقنين القنب باستهلاك المزيد منه للأغراض الطبية أو الترفيهية. علاوة على ذلك، سيعزز أيضًا تجارة القنب، وبالتالي يخلق المزيد من الطلب على القنب. وبالتالي، من المتوقع أن يؤدي تقنين القنب إلى دفع نمو السوق.

فرص

  • تطوير منتجات جديدة مع زيادة أنشطة البحث والتطوير

يأتي القنب الطبي في أشكال مختلفة عديدة بما في ذلك الكبسولات والعلكة القابلة للمضغ والكريمات والبلورات والزهور والأقراص والزيت وبخاخات الغشاء المخاطي للفم. أدى النمو المرتفع في الطلب على القنب مع إضفاء الشرعية على الحاجة إلى التوصل إلى سلالات منتجات وأنظمة توصيل أفضل. وقد دفع هذا العديد من الشركات إلى إجراء أنشطة البحث والتطوير للتحقق من استراتيجيات التحسين الجيني للقنب. تعمل لجنة منتجات القنب التابعة لإدارة الغذاء والدواء على تطوير وتنفيذ استراتيجيات وسياسات عبر الوكالات لتنظيم منتجات القنب. المنتجات الجديدة التي تم تطويرها وتزايدت هي مساحيق بروتين القنب وألواح الطاقة وحليب القنب ودقيق القنب وشاي القنب، والتي من المتوقع أن تخلق فرصًا لنمو السوق.

  • زيادة استخدام القنب لأغراض ترفيهية

إن تقنين الماريجوانا الترفيهية يؤدي إلى تنظيم مفيد لعقار آمن، دون زيادة العواقب السلبية المحتملة. إن تقنين الماريجوانا له فوائد مجتمعية مختلفة مثل ارتفاع الاقتصاد دون زيادة الضرائب، وخلق الآلاف من فرص العمل، ووقف الاختلافات العرقية في إنفاذ الماريجوانا، وتحرير موارد الشرطة الشحيحة. يمكن أن يؤدي تقنين الماريجوانا الترفيهية إلى إنهاء فرض قوانين الماريجوانا المكلفة وإضعاف سوق الماريجوانا غير القانونية.

وبفضل هذه الفوائد، تم تشريع الماريجوانا وتبنيها بشكل متزايد من قبل أشخاص من مختلف الفئات العمرية. وهذا يخلق طلبًا على الماريجوانا عالية الجودة من أجل المتعة والاسترخاء. وبالتالي، من المتوقع أن يؤدي التبني المتزايد للقنب لأغراض ترفيهية إلى خلق فرص للمصنعين في السوق.

ضبط النفس/التحدي

  • شراء باهظ التكلفة والتسرع في الحصول على الجودة الممتازة

قد تكون تكلفة تصنيع وشراء أجهزة القنب الطبي باهظة الثمن، وقد تكون تكلفة الإجراء مرتفعة أيضًا بسبب المعدات المتخصصة والتدريب المطلوب. وقد يحد هذا من إمكانية الوصول إلى علاجات القنب الطبي للمرضى ومرافق الرعاية الصحية، وخاصة في المناطق ذات الدخل المنخفض. بالإضافة إلى ذلك، قد تمنع التكلفة المرتفعة لأجهزة وإجراءات القنب الطبي بعض المرضى من اختيار هذه العلاجات، خاصة إذا كان عليهم الدفع من جيوبهم الخاصة. كما يمكن أن تكون التغطية التأمينية لعلاجات القنب الطبي محدودة، مما يحد من تبنيها.

ونتيجة لذلك، فإن التكلفة المرتفعة لأجهزة وإجراءات القنب الطبي يمكن أن تشكل عائقًا كبيرًا أمام نمو السوق، وخاصة في المناطق حيث التكلفة هي عامل رئيسي. ومع ذلك، مع تقدم التكنولوجيا، قد تنخفض تكلفة هذه الأجهزة والإجراءات، مما يجعلها في متناول المرضى ومرافق الرعاية الصحية.

ومن المتوقع أن يؤدي التعقيد المتزايد لأجهزة القنب الطبي والتكلفة العالية لعلاج القنب الطبي إلى كبح نمو السوق.

التطورات الأخيرة

  • في مايو 2018، وفقًا لقانون القنب الصادر عن حكومة كندا، سيخلق قانون القنب إطارًا قانونيًا صارمًا للسيطرة على إنتاج وتوزيع وبيع وحيازة القنب في جميع أنحاء كندا والذي يهدف إلى إبقاء القنب بعيدًا عن أيدي الشباب والأرباح بعيدًا عن جيوب الجريمة المنظمة من خلال تعزيز صناعة قانونية ومنظمة قوية.

نطاق سوق القنب الطبي في الشرق الأوسط وأفريقيا

يتم تقسيم سوق القنب الطبي في الشرق الأوسط وأفريقيا إلى تسعة قطاعات بارزة بناءً على المنتج والمصدر والأنواع والمشتقات والتطبيق وطريقة الإدارة ونوع العلاج والمستخدم النهائي وقناة التوزيع. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات نمو السوق في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.

منتج

  • زيت
  • القنب الطبي المجفف
  • كبسولات القنب الطبي
  • قلم فيب
  • الزهرة كاملة
  • كريمات ومرطبات
  • زهرة الارض
  • رقعة
  • أقنعة و مصل
  • منظف
  • آحرون

على أساس المنتج، يتم تقسيم السوق إلى زيت، كبسولات القنب الطبي، رقعة، زهرة كاملة، زهرة مطحونة، قلم vape، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها .

مصدر

  • اصطناعي
  • طبيعي

على أساس المصدر، يتم تقسيم السوق إلى اصطناعية وطبيعية.

صِنف

  • القنب الهندي
  • ساتيفا
  • هجين

على أساس الأنواع، يتم تقسيم السوق إلى القنب إنديكا، وساتيفا، والهجين.

المشتقات

  • كانابيديول (CBD)
  • رباعي هيدرو كانابينول (THC)/ دلتا-8-رباعي هيدرو كانابينول
  • كانابيجيرول (CBG)
  • كانابيكرومين (CBC)
  • كانابينول (CBN)
  • كانابيسايكلول (CBL)
  • آحرون

على أساس المشتقات، يتم تقسيم السوق إلى كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها.

طلب

  • إدارة الألم
  • قلق
  • تشنّج عضلي
  • غثيان
  • فقدان الشهية
  • اضطرابات الأكل
  • أمراض الأمعاء الالتهابية
  • سرطان
  • التهاب المفاصل
  • متلازمة الهزال (الهزال)
  • مرض الزهايمر
  • الصرع
  • الاكتئاب واضطرابات النوم
  • تصلب متعدد
  • توحد
  • حالات الصحة العقلية
  • تحسين المزاج
  • آحرون

على أساس التطبيق، يتم تقسيم السوق إلى مرض الزهايمر، وفقدان الشهية، والسرطان، وأمراض الأمعاء الالتهابية، واضطرابات الأكل، والصرع، والتوحد، وحالات الصحة العقلية، والتصلب المتعدد، وإدارة الألم، والغثيان، وتشنجات العضلات، ومتلازمة الهزال (الضمور العضلي)، وتحسين الحالة المزاجية، والتصلب المتعدد، والاكتئاب واضطرابات النوم، والقلق، وغيرها.

طريق الإدارة

  • المحاليل الفموية والكبسولات
  • تدخين
  • مبخرات
  • المواضيع
  • آحرون

على أساس طريق الإدارة، يتم تقسيم السوق إلى حلول فموية وكبسولات، وتدخين، وأجهزة تبخير، وموضعية، وغيرها.

نوع العلاج

  • مسكن
  • مخدر
  • مضاد فيروسات
  • مثير للشهوة الجنسية
  • مقشع
  • آحرون

على أساس نوع العلاج، يتم تقسيم السوق إلى مقشع، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها.

المستخدم النهائي

  • إعداد الرعاية المنزلية
  • مستشفى
  • مراكز إعادة التأهيل
  • صناعة الادوية
  • مراكز البحث والتطوير
  • آحرون

على أساس المستخدم النهائي، يتم تقسيم السوق إلى صناعة الأدوية، ومراكز البحث والتطوير، وإعدادات الرعاية المنزلية، والمستشفيات، ومراكز إعادة التأهيل، وغيرها.

قناة التوزيع

  • ب2ب
  • ب2م

على أساس قناة التوزيع، يتم تقسيم السوق إلى B2B و B2C.

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

تحليل/رؤى إقليمية لسوق القنب الطبي في الشرق الأوسط وأفريقيا

يتم تقسيم سوق القنب الطبي في الشرق الأوسط وأفريقيا إلى تسعة قطاعات بارزة بناءً على المنتج والمصدر والأنواع والمشتقات والتطبيق وطريقة الإدارة ونوع العلاج والمستخدم النهائي وقناة التوزيع.

الدول التي يغطيها تقرير السوق هذا هي إسرائيل وجنوب أفريقيا ولبنان والإمارات العربية المتحدة والكويت وبقية دول الشرق الأوسط وأفريقيا.

ومن المتوقع أن تهيمن إسرائيل على سوق القنب الطبي في الشرق الأوسط وأفريقيا بسبب أنشطة البحث والتطوير المتزايدة في البلاد.

كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية الإقليمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير قنوات المبيعات أثناء تقديم تحليل تنبؤي لبيانات الدولة.

تحليل المشهد التنافسي وحصة سوق القنب الطبي في الشرق الأوسط وأفريقيا

يقدم المشهد التنافسي لسوق القنب الطبي في الشرق الأوسط وأفريقيا تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور الإقليمي، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف للشركة، وإطلاق المنتج، وخطوط أنابيب التجارب السريرية، وتحليل العلامة التجارية، وموافقات المنتج، وبراءات الاختراع، وعرض المنتج ونطاقه، وهيمنة التطبيق، ومنحنى شريان الحياة التكنولوجي. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بالسوق.

بعض اللاعبين الرئيسيين في السوق الذين يعملون في هذا السوق هم MediPharm Labs Inc. و Tilray و Aurora Cannabis و JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc) و HEXO Corp. (Zenabis Middle East and Africa Ltd) و Cresco Labs و Peace Naturals Project Inc. و CANOPY GROWTH CORPORATION و Medical Marijuana, Inc. و Seed Cellar و EcoGen Biosciences و CANNABIS SEEDS USA و Seeds For Me و HUMBOLDT SEED COMPANY و Extractas و World Class Cannabis Seeds (Crop King Seeds) و BARNEY'S FARM و FOLIUM BIOSCIENCES و PharmaHemp و Elixinol Middle East and Africa Limited و ENDOCA و Harmony و MARY'S nutritions, LLC و Pure Ratios و Greenwich Biosciences, Inc. و Upstate Elevator Supply Co. و Apothecanna. BOL Pharma، وIDT Australia وغيرها.

SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

Sample Image انقر على الصورة للتكبير
  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 INDUSTRY INSIGHTS

5.1 INDUSTRY INSIGHTS PATENT ANALYSIS

5.2 DRUG TREATMENT RATE BY MATURED MARKETS

5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

5.4 PATIENT FLOW DIAGRAM

5.5 KEY PRICING STRATEGIES

5.6 KEY PATIENT ENROLLMENT STRATEGIES

6 REGULATORY SCENARIO

6.1 SOUTH AFRICA

6.2 U.A.E.

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED USE OF CANNABIS IN MEDICINES

7.1.2 LEGALIZATION OF CANNABIS

7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS

7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS

7.2 RESTRAINTS

7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS

7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE

7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY

7.3 OPPORTUNITIES

7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES

7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES

7.3.3 GROWING GERIATRIC POPULATION

7.4 CHALLENGES

7.4.1 RISE OF THE CANNABIS BLACK MARKET

7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS

7.4.3 SHORTAGE OF SKILLED PERSONNEL

8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 OIL

8.2.1 OIL, BY TYPE

8.2.1.1 CBD OIL CONCENTRATES

8.2.1.2 CBD VAPE OIL

8.2.1.3 CBD TINCTURES

8.2.2 OIL, BY SOURCE

8.2.2.1 HEMP BASED

8.2.2.2 MARIJUANA BASED

8.2.3 OIL, BY SPECIES

8.2.3.1 SATIVA

8.2.3.2 HYBRID

8.2.3.3 CANNABIS INDICA

8.2.4 OIL, BY PRODUCT TYPE

8.2.4.1 BRANDED

8.2.4.1.1 PENGUIN CBD OIL

8.2.4.1.2 FAB CBD OIL

8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL

8.2.4.1.4 OTHERS

8.2.4.2 GENERIC

8.3 DRIED MEDICAL CANNABIS

8.3.1 CANNABIS INDICA

8.3.2 SATIVA

8.3.3 HYBRID

8.4 MEDICAL CANNABIS CAPSULES

8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE

8.4.1.1 OIL BASED CANNABIS CAPSULES

8.4.1.2 POWDER BASED CANNABIS CAPSULES

8.4.1.3 LIQUID BASED CANNABIS CAPSULES

8.4.1.4 OTHERS

8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES

8.4.2.1 HIGH CBD CAPSULES DIGITAL

8.4.2.2 HIGH THC CAPSULE

8.4.2.3 THC/CBD BALANCED CAPSULE

8.4.2.4 CBD ISOLATE CAPSULE

8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES

8.4.3.1 SATIVA

8.4.3.2 CANNABIS INDICA

8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE

8.4.4.1 BRANDED

8.4.4.1.1 JOY NUTRITION

8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES

8.4.4.1.3 LAZARUS NATURALS

8.4.4.1.4 OTHERS

8.4.4.2 GENERIC

8.5 VAPE PEN

8.5.1 VAPE PEN, BY SPECIES

8.5.1.1 SATIVA

8.5.1.2 HYBRID

8.5.1.3 CANNABIS INDICA

8.5.2 VAPE PEN, BY PRODUCT TYPE

8.5.2.1 BRANDED

8.5.2.1.1 KANDYPENS RUBI

8.5.2.1.2 SOL E-NECTAR COLLECTOR

8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN

8.5.2.2 GENERIC

 

8.6 WHOLE FLOWER

8.6.1 WHOLE FLOWER, SPECIES

8.6.1.1 SATIVA

8.6.1.2 HYBRID

8.6.1.3 CANNABIS INDICA

8.6.2 WHOLE FLOWER, PRODUCT TYPE

8.6.2.1 BRANDED

8.6.2.1.1 ASTER FARMS

8.6.2.1.2 RA FLOWER

8.6.2.1.3 BAD APPLE

8.6.2.2 GENERIC

8.7 CREAMS & MOISTURIZER

8.7.1 CREAMS & MOISTURIZER, BY SPECIES

8.7.1.1 SATIVA

8.7.1.2 HYBRID

8.7.1.3 CANNABIS INDICA

8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE

8.7.2.1 BRANDED

8.7.2.1.1 CBDFX MUSCLE & JOINT

8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM

8.7.2.1.3 MEDTERRA PAIN CREAM

8.7.2.2 GENERIC

8.8 GROUND FLOWER

8.8.1 GROUND FLOWER, BY SPECIES

8.8.1.1 SATIVA

8.8.1.2 HYBRID

8.8.1.3 CANNABIS INDICA

8.8.2 GROUND FLOWER, BY PRODUCT TYPE

8.8.2.1 BRANDED

8.8.2.1.1 ASTER FARMS

8.8.2.1.2 RA FLOWER

8.8.2.1.3 BAD APPLE

8.8.2.2 GENERIC

8.9 PATCH

8.9.1 PATCH, BY TYPE

8.9.1.1 RESERVOIR

8.9.1.2 LAYER DRUG-IN-ADHESIVE

8.9.1.3 OTHERS

 

8.9.2 PATCH, BY SPECIES

8.9.2.1 SATIVA

8.9.2.2 CANNABIS INDICA

8.9.2.3 HYBRID

8.9.3 PATCH, BY PRODUCT TYPE

8.9.3.1 BRANDED

8.9.3.1.1 HEMP BOMBS

8.9.3.1.2 PUREKANA

8.9.3.1.3 PURE RATIOS

8.9.3.1.4 RESERVOIR

8.9.3.2 GENERIC

8.1 MASKS & SERUM

8.10.1 MASKS & SERUM, BY SPECIES

8.10.1.1 SATIVA

8.10.1.2 CANNABIS INDICA

8.10.1.3 HYBRID

8.10.2 MASKS & SERUM, BY PRODUCT TYPE

8.10.2.1 BRANDED

8.10.2.1.1 BUMP & SMOOTH CBD

8.10.2.1.2 FACIAL ESSENCE

8.10.2.1.3 OTHERS

8.10.2.2 GENERIC

8.11 CLEANSER

8.11.1 CLEANSER, BY SPECIES

8.11.1.1 SATIVA

8.11.1.2 HYBRID

8.11.1.3 CANNABIS INDICA

8.11.2 CLEANSER, BY PRODUCT TYPE

8.11.2.1 BRANDED

8.11.2.1.1 KIEHL’S

8.11.2.1.2 CBD 101

8.11.2.1.3 OTHERS

8.11.2.2 GENERIC

8.12 OTHERS

9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES

9.1 OVERVIEW

9.2 SATIVA

9.3 HYBRID

9.4 CANNABIS INDICA

10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES

10.1 OVERVIEW

10.2 CANNABIDIOL (CBD)

10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL

10.4 CANNABIGEROL (CBG)

10.5 CANNABICHROMENE (CBC)

10.6 CANNABINOL (CBN)

10.7 CANNABICYCLOL (CBL)

10.8 OTHERS

11 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 PAIN MANAGEMENT

11.2.1 PAIN MANAGEMENT, BY TYPE

11.2.1.1 CHRONIC PAIN

11.2.1.2 NON-CANCER CHRONIC PAIN

11.2.1.3 NEUROLOGICAL PAIN

11.2.2 PAIN MANAGEMENT, BY PRODUCT

11.2.2.1 OIL

11.2.2.2 DRIED MEDICAL CANNABIS

11.2.2.3 MEDICAL CANNABIS CAPSULES

11.2.2.4 PATCH

11.2.2.5 GROUND FLOWER

11.2.2.6 CREAMS & MOISTURIZER

11.2.2.7 VAPE PEN

11.2.2.8 WHOLE FLOWER

11.2.2.9 MASKS & SERUM

11.2.2.10 CLEANSER

11.2.2.11 OTHERS

11.3 ANXIETY

11.3.1 OIL

11.3.2 DRIED MEDICAL CANNABIS

11.3.3 MEDICAL CANNABIS CAPSULES

11.3.4 PATCH

11.3.5 GROUND FLOWER

11.3.6 CREAMS & MOISTURIZER

11.3.7 VAPE PEN

11.3.8 WHOLE FLOWER

11.3.9 MASKS & SERUM

11.3.10 CLEANSER

11.3.11 OTHERS

11.4 MUSCLE SPASM

11.4.1 OIL

11.4.2 DRIED MEDICAL CANNABIS

11.4.3 MEDICAL CANNABIS CAPSULES

11.4.4 PATCH

11.4.5 GROUND FLOWER

11.4.6 CREAMS & MOISTURIZER

11.4.7 VAPE PEN

11.4.8 WHOLE FLOWER

11.4.9 MASKS & SERUM

11.4.10 CLEANSER

11.4.11 OTHERS

11.5 NAUSEA

11.5.1 OIL

11.5.2 DRIED MEDICAL CANNABIS

11.5.3 MEDICAL CANNABIS CAPSULES

11.5.4 PATCH

11.5.5 GROUND FLOWER

11.5.6 CREAMS & MOISTURIZER

11.5.7 VAPE PEN

11.5.8 WHOLE FLOWER

11.5.9 MASKS & SERUM

11.5.10 CLEANSER

11.5.11 OTHERS

11.6 APPETITE LOSS

11.6.1 OIL

11.6.2 DRIED MEDICAL CANNABIS

11.6.3 MEDICAL CANNABIS CAPSULES

11.6.4 PATCH

11.6.5 GROUND FLOWER

11.6.6 CREAMS & MOISTURIZER

11.6.7 VAPE PEN

11.6.8 WHOLE FLOWER

11.6.9 MASKS & SERUM

11.6.10 CLEANSER

11.6.11 OTHERS

 

11.7 EATING DISORDERS

11.7.1 OIL

11.7.2 DRIED MEDICAL CANNABIS

11.7.3 MEDICAL CANNABIS CAPSULES

11.7.4 PATCH

11.7.5 GROUND FLOWER

11.7.6 CREAMS & MOISTURIZER

11.7.7 VAPE PEN

11.7.8 WHOLE FLOWER

11.7.9 MASKS & SERUM

11.7.10 CLEANSER

11.7.11 OTHERS

11.8 INFLAMMATORY BOWEL DISEASES

11.8.1 OIL

11.8.2 DRIED MEDICAL CANNABIS

11.8.3 MEDICAL CANNABIS CAPSULES

11.8.4 PATCH

11.8.5 GROUND FLOWER

11.8.6 CREAMS & MOISTURIZER

11.8.7 VAPE PEN

11.8.8 WHOLE FLOWER

11.8.9 MASKS & SERUM

11.8.10 CLEANSER

11.8.11 OTHERS

11.9 CANCER

11.9.1 OIL

11.9.2 DRIED MEDICAL CANNABIS

11.9.3 MEDICAL CANNABIS CAPSULES

11.9.4 PATCH

11.9.5 GROUND FLOWER

11.9.6 CREAMS & MOISTURIZER

11.9.7 VAPE PEN

11.9.8 WHOLE FLOWER

11.9.9 MASKS & SERUM

11.9.10 CLEANSER

11.9.11 OTHERS

 

11.1 ARTHRITIS

11.10.1 OIL

11.10.2 DRIED MEDICAL CANNABIS

11.10.3 MEDICAL CANNABIS CAPSULES

11.10.4 PATCH

11.10.5 GROUND FLOWER

11.10.6 CREAMS & MOISTURIZER

11.10.7 VAPE PEN

11.10.8 WHOLE FLOWER

11.10.9 MASKS & SERUM

11.10.10 CLEANSER

11.10.11 OTHERS

11.11 WASHING SYNDROME (CACHEXIA)

11.11.1 OIL

11.11.2 DRIED MEDICAL CANNABIS

11.11.3 MEDICAL CANNABIS CAPSULES

11.11.4 PATCH

11.11.5 GROUND FLOWER

11.11.6 CREAMS & MOISTURIZER

11.11.7 VAPE PEN

11.11.8 WHOLE FLOWER

11.11.9 MASKS & SERUM

11.11.10 CLEANSER

11.11.11 OTHERS

11.12 ALZHEIMER’S DISEASE

11.12.1 OIL

11.12.2 DRIED MEDICAL CANNABIS

11.12.3 MEDICAL CANNABIS CAPSULES

11.12.4 PATCH

11.12.5 GROUND FLOWER

11.12.6 CREAMS & MOISTURIZER

11.12.7 VAPE PEN

11.12.8 WHOLE FLOWER

11.12.9 MASKS & SERUM

11.12.10 CLEANSER

11.12.11 OTHERS

 

11.13 EPILEPSY

11.13.1 OIL

11.13.2 DRIED MEDICAL CANNABIS

11.13.3 MEDICAL CANNABIS CAPSULES

11.13.4 PATCH

11.13.5 GROUND FLOWER

11.13.6 CREAMS & MOISTURIZER

11.13.7 VAPE PEN

11.13.8 WHOLE FLOWER

11.13.9 MASKS & SERUM

11.13.10 CLEANSER

11.13.11 OTHERS

11.14 DEPRESSION AND SLEEP DISORDER

11.14.1 OIL

11.14.2 DRIED MEDICAL CANNABIS

11.14.3 MEDICAL CANNABIS CAPSULES

11.14.4 PATCH

11.14.5 GROUND FLOWER

11.14.6 CREAMS & MOISTURIZER

11.14.7 VAPE PEN

11.14.8 WHOLE FLOWER

11.14.9 MASKS & SERUM

11.14.10 CLEANSER

11.14.11 OTHERS

11.15 MULTIPLE SCLEROSIS

11.15.1 OIL

11.15.2 DRIED MEDICAL CANNABIS

11.15.3 MEDICAL CANNABIS CAPSULES

11.15.4 PATCH

11.15.5 GROUND FLOWER

11.15.6 CREAMS & MOISTURIZER

11.15.7 VAPE PEN

11.15.8 WHOLE FLOWER

11.15.9 MASKS & SERUM

11.15.10 CLEANSER

11.15.11 OTHERS

 

11.16 AUTISM

11.16.1 OIL

11.16.2 DRIED MEDICAL CANNABIS

11.16.3 MEDICAL CANNABIS CAPSULES

11.16.4 PATCH

11.16.5 GROUND FLOWER

11.16.6 CREAMS & MOISTURIZER

11.16.7 VAPE PEN

11.16.8 WHOLE FLOWER

11.16.9 MASKS & SERUM

11.16.10 CLEANSER

11.16.11 OTHERS

11.17 MENTAL HEALTH CONDITIONS

11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)

11.17.1.2 SCHIZOPHRENIA

11.17.1.3 OTHERS

11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.2.1 OIL

11.17.2.2 DRIED MEDICAL CANNABIS

11.17.2.3 MEDICAL CANNABIS CAPSULES

11.17.2.4 PATCH

11.17.2.5 GROUND FLOWER

11.17.2.6 CREAMS & MOISTURIZER

11.17.2.7 VAPE PEN

11.17.2.8 WHOLE FLOWER

11.17.2.9 MASKS & SERUM

11.17.2.10 CLEANSER

11.17.2.11 OTHERS

11.18 ELEVATE MOOD

11.18.1 OIL

11.18.2 DRIED MEDICAL CANNABIS

11.18.3 MEDICAL CANNABIS CAPSULES

11.18.4 PATCH

11.18.5 GROUND FLOWER

11.18.6 CREAMS & MOISTURIZER

11.18.7 VAPE PEN

11.18.8 WHOLE FLOWER

11.18.9 MASKS & SERUM

11.18.10 CLEANSER

11.18.11 OTHERS

11.19 OTHERS

12 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 ORAL SOLUTIONS AND CAPSULES

12.3 SMOKING

12.4 TOPICALS

12.5 VAPORIZERS

12.6 OTHERS

13 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE

13.1 OVERVIEW

13.2 ANALGESIC

13.3 PSYCHEDELIC

13.4 ANTIVIRAL

13.5 APHRODISIAC

13.6 EXPECTORANT

13.7 OTHERS

14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOMECARE SETTING

14.3 HOSPITAL

14.4 REHAB CENTERS

14.5 PHARMACEUTICAL INDUSTRY

14.6 RESEARCH AND DEVELOPMENT CENTERS

14.7 OTHERS

15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 B2C

15.2.1 PHARMACIES

15.2.2 CONVENTIONAL STORES

15.2.3 ONLINE STORES

15.2.4 OTHERS

15.3 B2B

 

16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY REGION

16.1 MIDDLE EAST AND AFRICA

16.1.1 ISRAEL

16.1.2 SOUTH AFRICA

16.1.3 LEBANON

16.1.4 U.A.E.

16.1.5 KUWAIT

16.1.6 REST OF MIDDLE EAST AND AFRICA

17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

18 COMPANY PROFILE

18.1 MEDIPHARM LABS INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 TILRAY

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 AURORA CANNABIS

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

 

18.5 HEXO CORP. (ZENABIS MIDDLE EAST & AFRICA LTD)

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 APOTHECANNA

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 BOL PHARMA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 BARNEY’S FARM

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 CANOPY GROWTH CORPORATION

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 CANNABIS SEEDS USA

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 CRESCO LABS

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENTS

18.12 ECOGEN BIOSCIENCES

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENTS

18.13 ELIXINOL MIDDLE EAST & AFRICA LIMITED

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENTS

18.14 ENDOCA

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 EXTRACTAS

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 FOLIUM BIOSCIENCES

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENTS

18.17 GREENWICH BIOSCIENCES, INC.

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENTS

18.18 HARMONY

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 HUMBOLDT SEED COMPANY

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 IDT AUSTRALIA

18.20.1 COMPANY SNAPSHOT

18.20.2 REVENUE ANALYSIS

18.20.3 PRODUCT PORTFOLIO

18.20.4 RECENT DEVELOPMENTS

18.21 MARY’S NUTRITIONALS, LLC

18.21.1 COMPANY SNAPSHOT

18.21.2 PRODUCT PORTFOLIO

18.21.3 RECENT DEVELOPMENT

18.22 MEDICAL MARIJUANA, INC.

18.22.1 COMPANY SNAPSHOT

18.22.2 REVENUE ANALYSIS

18.22.3 PRODUCT PORTFOLIO

18.22.4 RECENT DEVELOPMENTS

 

18.23 PEACE NATURALS PROJECT INC.

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 PHARMAHEMP

18.24.1 COMPANY SNAPSHOT

18.24.2 PRODUCT PORTFOLIO

18.24.3 RECENT DEVELOPMENT

18.25 PURE RATIOS

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

18.26 SEEDS FOR ME

18.26.1 COMPANY SNAPSHOT

18.26.2 PRODUCT PORTFOLIO

18.26.3 RECENT DEVELOPMENT

18.27 SEED CELLAR

18.27.1 COMPANY SNAPSHOT

18.27.2 PRODUCT PORTFOLIO

18.27.3 RECENT DEVELOPMENT

18.28 UPSTATE ELEVATOR SUPPLY CO.

18.28.1 COMPANY SNAPSHOT

18.28.2 PRODUCT PORTFOLIO

18.28.3 RECENT DEVELOPMENT

18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)

18.29.1 COMPANY SNAPSHOT

18.29.2 PRODUCT PORTFOLIO

18.29.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 2 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 63 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 65 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 67 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 69 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 71 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 73 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 75 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 77 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 79 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 81 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 83 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 84 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 85 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 87 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 89 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 91 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 94 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 96 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 97 MIDDLE EAST & AFRICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 98 MIDDLE EAST & AFRICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 99 MIDDLE EAST & AFRICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 100 MIDDLE EAST & AFRICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 101 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 102 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 103 MIDDLE EAST & AFRICA ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 104 MIDDLE EAST & AFRICA PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 105 MIDDLE EAST & AFRICA ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 106 MIDDLE EAST & AFRICA APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 107 MIDDLE EAST & AFRICA EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 108 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 109 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 MIDDLE EAST & AFRICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 111 MIDDLE EAST & AFRICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 112 MIDDLE EAST & AFRICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 113 MIDDLE EAST & AFRICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 114 MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 115 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 116 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 117 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 118 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 119 MIDDLE EAST & AFRICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 120 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 121 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 124 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 125 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 126 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 MIDDLE EAST AND AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 129 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 130 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 131 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 134 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 137 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 138 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 140 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 141 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 142 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 143 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 147 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 150 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 153 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 154 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 156 MIDDLE EAST AND AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 157 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 158 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 159 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 MIDDLE EAST AND AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 MIDDLE EAST AND AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 MIDDLE EAST AND AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 167 MIDDLE EAST AND AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 168 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 MIDDLE EAST AND AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 173 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 177 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 181 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 182 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 183 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 ISRAEL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 185 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 187 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 188 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 189 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 ISRAEL DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 192 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 193 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 194 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 196 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 197 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 200 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 202 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 203 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 206 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 208 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 210 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 213 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 216 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 217 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 ISRAEL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 219 ISRAEL SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 220 ISRAEL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 221 ISRAEL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 222 ISRAEL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 224 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 225 ISRAEL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 ISRAEL MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 ISRAEL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 ISRAEL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 229 ISRAEL EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 ISRAEL INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 ISRAEL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 ISRAEL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 ISRAEL WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 ISRAEL ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 ISRAEL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 ISRAEL DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 237 ISRAEL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 238 ISRAEL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 239 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 241 ISRAEL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 ISRAEL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 243 ISRAEL MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 244 ISRAEL MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 245 ISRAEL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 246 ISRAEL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 247 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 248 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 249 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 250 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 251 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 253 SOUTH AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 254 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 255 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 256 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 257 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 258 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 259 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 260 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 261 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 263 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 264 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 266 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 267 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 268 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 269 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 270 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 271 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 272 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 273 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 274 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 275 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 276 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 277 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 278 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 279 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 282 SOUTH AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 283 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 284 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 285 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 286 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 288 SOUTH AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 289 SOUTH AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 290 SOUTH AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 291 SOUTH AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 292 SOUTH AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 293 SOUTH AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 294 SOUTH AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 295 SOUTH AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 296 SOUTH AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 SOUTH AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 298 SOUTH AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 SOUTH AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 SOUTH AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 SOUTH AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 303 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 304 SOUTH AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 305 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 306 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 307 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 SOUTH AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 310 LEBANON MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 311 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 312 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 313 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 314 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 315 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 316 LEBANON DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 317 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 319 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 320 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 321 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 323 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 324 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 326 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 328 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 329 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 331 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 332 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 333 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 336 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 338 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 339 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 342 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 343 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 LEBANON MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 345 LEBANON SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 346 LEBANON MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 347 LEBANON MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 348 LEBANON MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 350 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 351 LEBANON ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 LEBANON MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 LEBANON NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 LEBANON APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 LEBANON EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 356 LEBANON INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 357 LEBANON CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 358 LEBANON ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 359 LEBANON WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 360 LEBANON ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 361 LEBANON EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 362 LEBANON DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 363 LEBANON MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 364 LEBANON AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 365 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 367 LEBANON ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 368 LEBANON MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 369 LEBANON MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 370 LEBANON MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 371 LEBANON MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 372 LEBANON B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 373 U.A.E. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 374 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 375 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 376 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 377 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 378 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 379 U.A.E. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 380 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 381 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 382 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 383 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 384 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 386 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 387 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 388 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 389 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 390 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 391 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 392 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 393 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 394 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 395 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 396 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 397 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 398 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 399 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 400 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 401 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 402 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 403 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 404 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 405 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 406 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 407 U.A.E. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 408 U.A.E. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 409 U.A.E. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 410 U.A.E. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 411 U.A.E. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 412 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 413 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 414 U.A.E. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 415 U.A.E. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 416 U.A.E. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 417 U.A.E. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 418 U.A.E. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 419 U.A.E. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 420 U.A.E. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 421 U.A.E. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 422 U.A.E. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 423 U.A.E. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 424 U.A.E. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 425 U.A.E. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 426 U.A.E. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 427 U.A.E. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 428 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 429 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 430 U.A.E. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 431 U.A.E. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 432 U.A.E. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 433 U.A.E. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 434 U.A.E. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 435 U.A.E. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 436 KUWAIT MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 437 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 438 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 439 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 440 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 441 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 442 KUWAIT DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 443 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 444 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 445 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 446 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 447 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 448 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 449 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 450 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 451 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 452 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 453 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 454 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 455 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 456 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 458 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 459 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 461 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 462 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 463 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 464 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 465 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 466 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 467 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 468 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 469 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 470 KUWAIT MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 471 KUWAIT SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 472 KUWAIT MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 473 KUWAIT MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 474 KUWAIT MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 475 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 476 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 477 KUWAIT ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 478 KUWAIT MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 479 KUWAIT NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 480 KUWAIT APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 481 KUWAIT EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 482 KUWAIT INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 483 KUWAIT CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 484 KUWAIT ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 485 KUWAIT WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 486 KUWAIT ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 487 KUWAIT EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 488 KUWAIT DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 489 KUWAIT MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 490 KUWAIT AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 491 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 492 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 493 KUWAIT ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 494 KUWAIT MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 495 KUWAIT MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 496 KUWAIT MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 497 KUWAIT MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 498 KUWAIT B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 499 REST OF MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN 2023 AND 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET

FIGURE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2022

FIGURE 15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2022

FIGURE 19 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)

FIGURE 21 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022

FIGURE 23 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)

FIGURE 25 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION, 2022

FIGURE 27 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)

FIGURE 29 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 31 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 33 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 34 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022

FIGURE 35 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)

FIGURE 36 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)

FIGURE 37 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 38 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, 2022

FIGURE 39 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 40 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 41 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 43 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 44 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 45 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: SNAPSHOT (2022)

FIGURE 47 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022)

FIGURE 48 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 49 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)

FIGURE 50 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)

FIGURE 51 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The Middle East and Africa Medical Cannabis Market is projected to grow at a CAGR of 21.7% during the forecast period by 2030.
The Middle East and Africa Medical Cannabis Market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The major players in the Middle East and Africa Medical Cannabis Market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Global Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, etc.
The countries covered in the Middle East and Africa Medical Cannabis Market are Israel, South Africa, Lebanon, U.A.E., Kuwait, and rest of Middle East and Africa.

تصفح الصفحات ذات الصلة

Banner